Clinicoeconomics And Outcomes Research

Clinicoeconomics And Outcomes Research

临床经济学和成果研究

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Clinicoeconomics And Outcomes Research》是由Dove Medical Press出版社创办的英文国际期刊(ISSN: 1178-6981),该期刊长期致力于卫生保健与服务领域的创新研究,主要研究方向为HEALTH CARE SCIENCES & SERVICES。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比1%),以发表卫生保健与服务领域等方向的原创性研究为核心(研究类文章占比91.78%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在73篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinicoeconomics And Outcomes Research审稿周期约为16 Weeks。该刊近年未被列入国际预警名单,年发文量约73篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 73 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
HEALTH CARE SCIENCES & SERVICES 卫生保健与服务
4区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
HEALTH CARE SCIENCES & SERVICES 卫生保健与服务
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEALTH CARE SCIENCES & SERVICES ESCI Q2 89 / 194

54.4

学科:HEALTH CARE SCIENCES & SERVICES ESCI Q3 105 / 194

46.13

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEALTH CARE SCIENCES & SERVICES ESCI Q3 88 / 174

49.7

学科:HEALTH CARE SCIENCES & SERVICES ESCI Q3 91 / 175

48.29

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.2 SJR:0.785 SNIP:1.19
学科类别 分区 排名 百分位
大类:Economics, Econometrics and Finance 小类:Economics, Econometrics and Finance (miscellaneous) Q1 64 / 283

77%

大类:Economics, Econometrics and Finance 小类:Health Policy Q2 108 / 330

67%

期刊发文

  • Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case-Control Stud

    Author: Liu, Aimei; Liao, Yan; Ye, Juexian; Wang, Qing; Huang, Junli; Tang, Yucheng; Feng, Lizhen

    Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2026; Vol. 18, Issue , pp. -. DOI: 10.2147/CEOR.S577874

  • Association Between Willingness to Pay and Quality of Life in Acne Patients: A Cross-Sectional Study with a Nomogram for Individualized Predictio

    Author: Li, Xiangzi; Cen, Xintao; Ning, Ning; Li, Chao; Zhu, Yaqian; Liu, Jiarui; Zhu, Qian; He, Shiyu; Guan, Yang

    Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2026; Vol. 18, Issue , pp. -. DOI: 10.2147/CEOR.S579111

  • Pharmaceutical Manufacturing in China Innovation Performance: A Dynamic QCA Analysis Based on the WSR Perspectiv

    Author: Zhu, Wangwang; Tao, Shiqi; Zhou, Xiaoying; Fu, Rui

    Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2026; Vol. 18, Issue , pp. -. DOI: 10.2147/CEOR.S560908

  • The Economic Burden of Patients with Diabetic Peripheral Neuropathic Pain Based on a Real-World Study in Chin

    Author: Wang, Rosa; Xuan, Dennis; Xuan, Jianwei; Dai, Dong; Ye, Xin; Hu, Xiaohan

    Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2025; Vol. 17, Issue , pp. 437-446. DOI: 10.2147/CEOR.S501243

  • Health Economics Evaluation of Bictegravir/ Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in Chin

    Author: Wang, Wenjuan; Zhou, Dachuang; Zhou, Kejia; Zhang, Di; Li, Hao; Zhang, Hongliu; Jiang, Xin; Wang, Ruihua; Wang, Xi; Tang, Wenxi

    Journal: CLINICOECONOMICS AND OUTCOMES RESEARCH. 2025; Vol. 17, Issue , pp. 393-406. DOI: 10.2147/CEOR.S513601